Where did the coronavirus come from?

The coronavirus’s origin story likely features not one, but two animal species.
Sign up for the Freethink Weekly newsletter!
A collection of our favorite stories straight to your inbox

Our understanding of the novel coronavirus is advancing rapidly — seemingly every day, scientists are delivering new insights into how it spreads and how we might be able to treat or prevent infections.

But the answer to one question continues to elude everyone: Where did the coronavirus come from?

Some have speculated that the virus jumped from bats to humans via China’s wet markets. Others have pushed the conspiracy theory that it was created in a lab.

Now, a team of U.S. scientists has made a major breakthrough in the case of the coronavirus’s origin — one that could help in the fight against COVID-19.

So, Where Did the Coronavirus Come From?

The virus that causes COVID-19, SARS-CoV-2, is one of many coronaviruses, and not every coronavirus can infect every species. However, a coronavirus that starts in one species can evolve in ways that allow it to infect others.

According to a new study published in the journal Science Advances, that’s what happened with SARS-CoV-2 — only instead of evolving from just one species, it evolved from two before infecting humans.

SARS-CoV-2 has a rich evolutionary history.


Elena Giorgi

The study is the work of scientists from Duke University, Los Alamos National Laboratory, the University of Texas at El Paso, and New York University. They set out to identify the novel coronavirus’s origin by comparing its genome to the genomes of 43 other coronaviruses.

Through that analysis, they discovered that SARS-CoV-2’s closest genetic relative is a coronavirus that infects bats. That bat virus can’t easily infect humans, though, because its spike protein — the tool it uses to break into cells — lacks a key piece of genetic material needed for the task.

Meanwhile, the coronaviruses that infect pangolins (a.k.a. scaly anteaters) aren’t very similar to SARS-CoV-2 — but they do contain that key piece of the spike protein.

The researchers’ conclusion? SARS-CoV-2 evolved from both bat and pangolin coronaviruses.

“In our study, we demonstrated that indeed SARS-CoV-2 has a rich evolutionary history that included a reshuffling of genetic material between bat and pangolin coronavirus before it acquired its ability to jump to humans,” researcher Elena Giorgi said in a news release.

Using the Coronavirus’s Origin to our Advantage

This path to humans isn’t unusual for a coronavirus — the original SARS virus started in bats, then moved into civets before infecting people, while MERS went from bats to camels to humans.

Coronaviruses turn out to be very good at picking up new abilities like this, because if two different coronaviruses infect the same cell at the same time, they can easily swap or recombine their genes, which is perhaps how a pangolin spike protein ended up on a horseshoe bat virus.

Prior to the publication of this study, other researchers had already speculated that the pangolin was serving as a middleman of sorts between bats and humans in the transmission of SARS-CoV-2.

Now that we have evidence that bats and pangolins are likely key players in the coronavirus’s origin story, officials can crack down on their sale to ensure the virus doesn’t continue to infect new people.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Sign up for the Freethink Weekly newsletter!
A collection of our favorite stories straight to your inbox
Related
Potato chips or heroin? The debate on social media and mental health
Experts disagree on whether social media causes mental health issues in adolescents despite looking at the same data. Here’s why.
Scientists have invented a method to break down “forever chemicals” in our drinking water
Researchers have discovered a way to eliminate “forever chemicals,” or PFAS, which usually take hundreds or thousands of years to break down.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
The threat of avian flu — and what we can do to stop it
Avian flu is infecting cows on US dairy farms, and now a person has caught it — but new research could help us avoid a bird flu pandemic.
A dietician explains “Zepbound,” the newest weightloss drug
Zepbound recently joined the list of obesity-fighting drugs administered as injections that has been approved by the FDA.
Up Next
Contact Tracing
Subscribe to Freethink for more great stories